Under Lynn Stockwell’s litigation-tested leadership, Bright Green has executed a strategic transformation from reputational collapse to sovereign continuity. Through documented governance, indemnification oversight, and federal filings, Stockwell restored procedural integrity and repositioned the company as a federally compliant entity. Lynn Stockwell serves as Sponsor, CEO, and Chairwoman across all four entities, maintaining direct ownership and board control to enforce strategic continuity.
Meet the TeamLed by Chairwoman & CEO Lynn Stockwell, PharmAGRI's mission is to restore U.S. control over plant-based Schedule II–V pharmaceutical production and accelerate agricultural modernization through robotics, automation, and vertically integrated infrastructure.
Read MoreQuota–backed production of cannabinoids, atropine, scopolamine & psilocybin analogs for U.S. pharma buyers.
USDA–guaranteed CEA food production for school lunch programs, SNAP, and large grocers.
EB–5 immigrant investor structuring, Nasdaq equity issuance, and federal contract administration.
From the integration of Tesla Optimus humanoid robots to the deployment of advanced regulatory compliance robotics, PharmAGRI harnesses cutting-edge automation technologies to revolutionize traditionally labor-intensive sectors. By embedding intelligent systems into pharmaceutical, agricultural, and compliance operations, we transform complex workflows into streamlined.
Read MoreRegistered and equipped to administer DEA, USDA, and HHS contracts for food and drug supply.
Registered and equipped to administer DEA, USDA, and HHS contracts for food and drug supply.
From the integration of Tesla Optimus humanoid robots to the deployment of advanced regulatory compliance robotics, PharmAGRI harnesses cutting-edge automation technologies to revolutionize traditionally labor-intensive sectors. By embedding intelligent systems into pharmaceutica.